Junguo Ren

655 total citations
30 papers, 509 citations indexed

About

Junguo Ren is a scholar working on Molecular Biology, Complementary and alternative medicine and Neurology. According to data from OpenAlex, Junguo Ren has authored 30 papers receiving a total of 509 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 12 papers in Complementary and alternative medicine and 8 papers in Neurology. Recurrent topics in Junguo Ren's work include Neuroinflammation and Neurodegeneration Mechanisms (6 papers), Traditional Chinese Medicine Studies (6 papers) and Neurological Disease Mechanisms and Treatments (5 papers). Junguo Ren is often cited by papers focused on Neuroinflammation and Neurodegeneration Mechanisms (6 papers), Traditional Chinese Medicine Studies (6 papers) and Neurological Disease Mechanisms and Treatments (5 papers). Junguo Ren collaborates with scholars based in China, Australia and Japan. Junguo Ren's co-authors include Jianxun Liu, Mingjiang Yao, Norio Takagi, Cheng-Ren Lin, Xiaodi Fan, Xiao Han, Bo Yuan, Sai Liu, Peng Li and Jincai Hou and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Ethnopharmacology and Frontiers in Pharmacology.

In The Last Decade

Junguo Ren

28 papers receiving 504 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Junguo Ren China 11 248 107 88 79 76 30 509
Huafeng Pan China 14 313 1.3× 96 0.9× 94 1.1× 48 0.6× 62 0.8× 47 657
Deepshikha Pande Katare India 12 244 1.0× 72 0.7× 83 0.9× 70 0.9× 39 0.5× 51 704
Xingui Xiong China 14 295 1.2× 96 0.9× 82 0.9× 110 1.4× 50 0.7× 26 577
Qingsong Jiang China 15 268 1.1× 71 0.7× 39 0.4× 65 0.8× 77 1.0× 35 533
Yong Su China 15 365 1.5× 93 0.9× 68 0.8× 102 1.3× 49 0.6× 36 665
Qiqi Xin China 14 235 0.9× 129 1.2× 45 0.5× 86 1.1× 81 1.1× 36 609
Pengji Yi China 13 300 1.2× 63 0.6× 66 0.8× 89 1.1× 86 1.1× 15 542
Huanhuan Ren China 12 275 1.1× 92 0.9× 98 1.1× 91 1.2× 51 0.7× 26 544
Zhuyuan Fang China 12 210 0.8× 111 1.0× 43 0.5× 55 0.7× 39 0.5× 33 493
Jian-Hua Fu China 12 222 0.9× 99 0.9× 59 0.7× 55 0.7× 60 0.8× 37 506

Countries citing papers authored by Junguo Ren

Since Specialization
Citations

This map shows the geographic impact of Junguo Ren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junguo Ren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junguo Ren more than expected).

Fields of papers citing papers by Junguo Ren

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junguo Ren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junguo Ren. The network helps show where Junguo Ren may publish in the future.

Co-authorship network of co-authors of Junguo Ren

This figure shows the co-authorship network connecting the top 25 collaborators of Junguo Ren. A scholar is included among the top collaborators of Junguo Ren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junguo Ren. Junguo Ren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zheng, Jiarui, Weiming Wang, Wenting Song, et al.. (2025). Investigation of Fructus sophorae extract’s therapeutic mechanism in atrophic vaginitis based on network pharmacology and experimental validation. Frontiers in Pharmacology. 16. 1571976–1571976.
2.
Han, Xiao, Yehao Zhang, Yuanyuan Chen, et al.. (2024). Hydroxysafflor Yellow A Inhibits Pyroptosis and Protecting HUVECs from OGD/R via NLRP3/Caspase-1/GSDMD Pathway. Chinese Journal of Integrative Medicine. 30(11). 1027–1034. 5 indexed citations
3.
Yu, Qingyuan, Xian Zhou, Wenting Song, et al.. (2024). Cytokine Storm in COVID-19: Insight into Pathological Mechanisms and Therapeutic Benefits of Chinese Herbal Medicines. SHILAP Revista de lepidopterología. 11(7). 14–14. 4 indexed citations
4.
Gao, Yunxiao, et al.. (2023). Efficacy of traditional Chinese medicine on diabetic cardiomyopathy in animal models: a systematic review and meta-analysis. Frontiers in Pharmacology. 14. 1253572–1253572. 2 indexed citations
6.
Wang, Min, Hideki Hayashi, Mayumi Asada, et al.. (2023). Role of senkyunolide I in the promotion of neural stem/progenitor cell proliferation via the Akt/β-catenin pathway. Biomedicine & Pharmacotherapy. 168. 115683–115683. 2 indexed citations
7.
Zhang, Jun, Tong Zhang, Hong Jiang, et al.. (2023). Identification of the Main Chemical constituents and mechanism of Renshen Guben oral liquid against Renal Fibrosis. Chinese Medicine. 18(1). 56–56. 3 indexed citations
8.
Chen, Xiaoxiao, Min Hou, Kuo Yang, et al.. (2022). The TCM Preparation Feilike Mixture for the Treatment of Pneumonia: Network Analysis, Pharmacological Assessment and Silico Simulation. Frontiers in Pharmacology. 13. 794405–794405. 9 indexed citations
9.
Ma, Bo, Li Xu, Mingjiang Yao, et al.. (2021). Jiedu Tongluo Granules Ameliorates Post-stroke Depression Rat Model via Regulating NMDAR/BDNF Signaling Pathway. Frontiers in Pharmacology. 12. 662003–662003. 18 indexed citations
10.
Guo, Yanli, et al.. (2021). MiR-126 inhibits vascular endothelial cell apoptosis in rats with coronary heart disease through PI3K/Akt pathway. Minerva Surgery. 78(1). 96–97. 1 indexed citations
11.
Chen, Feiyu, Zhangfeng Zhong, Hor‐Yue Tan, et al.. (2020). Suppression of lncRNA MALAT1 by betulinic acid inhibits hepatocellular carcinoma progression by targeting IAPs via miR‐22‐3p. SHILAP Revista de lepidopterología. 10(6). 48 indexed citations
12.
Luo, Chenxi, Yehao Zhang, Hao Guo, et al.. (2020). Ferulic Acid Attenuates Hypoxia/Reoxygenation Injury by Suppressing Mitophagy Through the PINK1/Parkin Signaling Pathway in H9c2 Cells. Frontiers in Pharmacology. 11. 103–103. 35 indexed citations
13.
Yao, Mingjiang, Xiaodi Fan, Bo Yuan, et al.. (2019). Berberine inhibits NLRP3 Inflammasome pathway in human triple-negative breast cancer MDA-MB-231 cell. BMC Complementary and Alternative Medicine. 19(1). 216–216. 101 indexed citations
16.
Ren, Junguo, Dongzhi Wang, Lei Lei, Kang Li, & Jianxun Liu. (2017). [Preliminary analysis on relationship between traditional efficacy of Chinese medicine and modern pharmacological action].. PubMed. 42(10). 1979–1983. 6 indexed citations
17.
Chen, Mingxia, et al.. (2017). Tang Wang Ming Mu Granule Attenuates Diabetic Retinopathy in Type 2 Diabetes Rats. Frontiers in Physiology. 8. 1065–1065. 13 indexed citations
18.
Tang, Xilan, Jianxun Liu, Wei Dong, et al.. (2014). Protective Effect of Kaempferol on LPS plus ATP-Induced Inflammatory Response in Cardiac Fibroblasts. Inflammation. 38(1). 94–101. 77 indexed citations
20.
Li, Peng, Jian-Hua Fu, Jingkun Wang, Junguo Ren, & Jianxun Liu. (2011). Extract of Paris polyphylla Simth protects cardiomyocytes from anoxia-reoxia injury through inhibition of calcium overload. Chinese Journal of Integrative Medicine. 17(4). 283–289. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026